Jack Nathan Medical Corp. (JNH.V)
CAD 0.03
(0.0%)
CAD 0.03
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -4.95 Million CAD | 10.06% |
| 2023 | -5.5 Million CAD | -416.89% |
| 2022 | -7.53 Million CAD | -485.38% |
| 2021 | -10.11 Million CAD | -30.86% |
| 2020 | 196.26 Thousand CAD | -468.81% |
| 2019 | 778.25 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - CAD | -1.7% |
| 2024 Q1 | -451.32 Thousand CAD | 84.76% |
| 2024 Q3 | -557.11 Thousand CAD | -27.01% |
| 2024 Q2 | -975.16 Thousand CAD | -140.42% |
| 2024 Q4 | -2.38 Million CAD | -61.29% |
| 2023 Q2 | -975.16 Thousand CAD | 43.83% |
| 2023 Q4 | -1.67 Million CAD | -201.02% |
| 2023 FY | - CAD | -416.89% |
| 2023 Q1 | -1.73 Million CAD | -20.08% |
| 2023 Q3 | -557.11 Thousand CAD | 42.87% |
| 2022 Q2 | -1.71 Million CAD | -23.15% |
| 2022 Q1 | -1.39 Million CAD | 3.7% |
| 2022 FY | - CAD | -485.38% |
| 2022 Q4 | -1.44 Million CAD | 21.54% |
| 2022 Q3 | -1.84 Million CAD | -7.56% |
| 2021 Q1 | -83.2 Thousand CAD | -349.8% |
| 2021 FY | - CAD | -30.86% |
| 2021 Q4 | -1.44 Million CAD | -2853.48% |
| 2021 Q3 | -48.91 Thousand CAD | -108.5% |
| 2021 Q2 | 575.25 Thousand CAD | 791.35% |
| 2020 Q3 | -784.00 CAD | 99.05% |
| 2020 Q4 | -18.49 Thousand CAD | -2259.57% |
| 2020 Q2 | -82.93 Thousand CAD | -156.0% |
| 2020 FY | - CAD | -468.81% |
| 2020 Q1 | -32.39 Thousand CAD | -709.93% |
| 2019 FY | - CAD | 0.0% |
| 2019 Q4 | -4000.00 CAD | -100.0% |
| 2019 Q1 | -10.08 Thousand CAD | 0.0% |
| 2019 Q2 | -2000.00 CAD | 80.17% |
| 2019 Q3 | -2000.00 CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Premier Health of America Inc. | 5.86 Million CAD | 184.451% |